Advanced Enzyme - Gaining Ground By Innovation, New Tech: HDFC Securities Retail Research Initiates Coverage
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HDFC Securities Retail Research
Advanced Enzyme Technologies Ltd. is a leading player in enzymes and probiotics that play a crucial role in health and nutrition.
Its products have applications in various other end-user industries as well.
Despite being a small player in a $ 10 billion plus industry, the company has more than 700 clients spread across 45 countries and a comprehensive product basket of 68 enzymes and probiotics and over 400 proprietary products.
This market is dominated by the likes of Novozymes, Danisco, DSM, BASF, etc. which together account for ~75% of the market.
Advanced Enzyme is amongst the top-15 global enzyme companies having highest market share in India.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.